Optimising implementation, maximising the effectiveness and increasing participation in the national lung cancer screening programme.
Public Attitudes: analysis of online commentary following the announcement of the UK's national lung cancer screening programme. This research identified NHS capacity concerns as a novel barrier to participation and highlighted how smoking-related stigma and misinformation could deter high-risk individuals (https://onlinelibrary.wiley.com/doi/10.1111/hex.70568).
Widening participation: The NIHR-funded, multicentre, randomised IMPALA trial is aimed at increasing informed participation in lung cancer screening through participant navigation - a co-produced, validated, behaviour change intervention encompassing motivational interviewing, decision coaching and participant activation (https://doi.org/10.1186/ISRCTN33418225).
Risk reassessments: developing and evaluating models to predict future risk of lung cancer in initially-low risk LCS participants to determine "date of future eligibility" and inform the optimal timelines for reassessment (https://thorax.bmj.com/content/80/Suppl_2/A243).
